Circulating levels of resistin and risk of type 2 diabetes in men and women: Results from two prospective cohorts

Diabetes Care

Volumn 32, Issue 2, 2009, Pages 329-334

  Chen, Brian H ^a   Song, Yiqing ^b   Ding, Eric L ^c   Roberts, Christian K ^a,d   Manson, Joann E ^b,c   Rifai, Nader ^e   Buring, Julie E ^b,c,f   Gaziano, J Michael ^a,b   Liu, Simin ^a,g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; RESISTIN;

ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; POSTMENOPAUSE; SMOKING; BLOOD; BODY MASS; BODY SIZE; CASE CONTROL STUDY; COHORT ANALYSIS; FOLLOW UP; LIFESTYLE; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY; RACE; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; RISK; RISK ASSESSMENT; SEXUAL DEVELOPMENT;

BODY MASS INDEX; BODY SIZE; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; COHORT STUDIES; CONTINENTAL POPULATION GROUPS; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; POSTMENOPAUSE; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REFERENCE VALUES; RESISTIN; RISK; RISK ASSESSMENT; SEX CHARACTERISTICS;

EID: 61849130650     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-1625     Document Type: Article

References (25)

1. Satoh H, Nguyen MT, Miles PD, Imamura T, Usui I, Olefsky JM: Adenovirus-medi- ated chronic "hyper-resistinemia" leads to in vivo insulin resistance in normal rats. J Clin Invest 114:224-231, 2004
2. Kim KH, Zhao L, MoonY, Kang C, Sul HS: Dominant inhibitory adipocyte-specific secretory factor (ADSF)/resistin enhances adipogenesis and improves insulin sensitivity. Proc Natl Acad SciUSA 101:6780-6785, 2004
3. Banerjee RR, Rangwala SM, Shapiro JS, Rich AS, Rhoades B, Qi Y, Wang J, Rajala MW, Pocai A, Scherer PE, Steppan CM, Ahima RS, Obici S, Rossetti L, Lazar MA: Regulation of fasted blood glucose by re- sistin. Science 303:1195-1198, 2004
4. Tokuyama Y, Osawa H, Ishizuka T, Onuma H, Matsui K, Egashira T, Makino H, Kanatsuka A: Serum resistin level is associated with insulin sensitivity in Japanese patients with type 2 diabetes mellitus. Metabolism 56:693-698, 2007
5. Fujinami A, Obayashi H, Ohta K, Ichimura T, Nishimura M, Matsui H, Kawahara Y, Yamazaki M, Ogata M, Ha- segawa G, Nakamura N, Yoshikawa T, Nakano K, Ohta M: Enzyme-linked im- munosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes. Clin Chim Acta 339:57-63, 2004
6. Youn BS, Yu KY, Park HJ, Lee NS, Min SS, Youn MY, Cho YM, Park YJ, Kim SY, Lee HK, Park KS: Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. J Clin Endocrinol Metab 89:150 -156, 2004
7. Bajaj M, Suraamornkul S, Hardies LJ, Pratipanawatr T, DeFronzo RA: Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients. Int J Obes Relat Metab Disord 28:783-789, 2004
8. Majuri A, Santaniemi M, Rautio K, Kun- nari A, Vartiainen J, Ruokonen A, Ke- saniemi YA, Tapanainen JS, Ukkola O, Morin-Papunen L: Rosiglitazone treatment increases plasma levels of adiponec- tin and decreases levels of resistin in overweight women with PCOS: a randomized placebo-controlled study. Eur J Endocrinol 156:263-269, 2007
9. Curat CA, Wegner V, Sengenes C, Miran- ville A, Tonus C, Busse R, Bouloumie A: Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Dia-betologia 49:744-747, 2006
10. Nagaev I, Smith U: Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun 285: 561-564, 2001
11. Buring JE, Hennekens CH: The Women's Health Study: summary of the study design. J Myocard Ischemia 4:27-29, 1992
12. Rexrode KM, Lee IM, Cook NR, Hennekens CH, Buring JE: Baseline characteristics of participants in the Women's Health Study. J Womens Health Gend Based Med 9:19-27, 2000
13. Christen WG, Gaziano JM, Hennekens CH: Design of Physicians' Health Study II-a randomized trial of β-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Ann Epidemiol 10:125-134, 2000
14. Song Y, Manson JE, Buring JE, Liu S: A prospective study of red meat consumption and type 2 diabetes in middle-aged and elderly women: the Women's Health Study. Diabetes Care 27:2108-2115, 2004
15. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
16. Liu S, Lee IM, Song Y, Van Denburgh M, Cook NR, Manson JE, Buring JE: Vitamin E and risk of type 2 diabetes in the Women's Health Study randomized controlled trial. Diabetes 55:2856 -2862, 2006
17. Blake GJ, Pradhan AD, Manson JE, Williams GR, Buring J, Ridker PM, Glynn RJ: Hemoglobin A1c level and future cardiovascular events among women. Arch Intern Med 164:757-761, 2004
18. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR: Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347: 1557-1565, 2002
19. Heidemann C, Sun Q, van Dam RM, Meigs JB, Zhang C, Tworoger SS, Mantzo- ros CS, Hu FB: Total and high-molecular- weight adiponectin and resistin in relation to the risk for type 2 diabetes in women. Ann Intern Med 149:307-316, 2008
20. Norata GD, Ongari M, Garlaschelli K, Ra- selli S, Grigore L, Catapano AL: Plasma resistin levels correlate with determinants of the metabolic syndrome. Eur J Endocrinol 156:279-284, 2007
21. Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A: Resistin, an adipokine with potent proinflammatory properties. J Immunol 174:5789-5795, 2005
22. McTernan PG, McTernan CL, Chetty R, Jenner K, Fisher FM, Lauer MN, Crocker J, Barnett AH, Kumar S: Increased resistin
23. gene and protein expression in human abdominal adipose tissue. J Clin Endocrinol Metab 87:2407, 2002
24. Weisberg SP, McCann D, Desai M, Rosen- baum M, Leibel RL, Ferrante AW Jr: Obesity is associated with macrophage accumulation in adipose tissue. JClin Invest 112:1796-1808, 2003
25. Ding EL, Song Y, Manson JE, Pradhan AD, Buring JE, Liu S: Accuracy of administrative coding for type 2 diabetes in children, adolescents, and young adults. Diabetes Care 30:e98; author reply e99, 2007